Physician

Sreekanth Chintamaneni, M.D.

According to 2025 Medicare claims, Sreekanth Chintamaneni, M.D. (NPI: 1427118280) practices rheumatology in the Redding, CA market, with the plurality of this provider's patient population coming from Shasta, CA. This provider's primary affiliated billing organization is RHEUMATOLOGY ASSOCIATES PC (NPI: 1326898594) and primary practice location at 96001-0160. Chintamaneni is affiliated with the Kootenai Accountable Care, LLC (ACO ID: A3621), Aledade 45 CA CHC MSSP Enhanced (ACO ID: A4542), and Gundersen ACO (ACO ID: A5094), participating under the MSSP model.

Chintamaneni's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 198 traditional Medicare patients, billed 2,041 HCPCS/CPT codes, and received $64,576 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 1,119 prescription claims across 209 beneficiaries totaling $1,320,050 in drug costs, led by Humira(Cf) Pen (Adalimumab). Open Payments data shows 14 records totaling $293. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, this provider has fewer than 5 years of reported Part D prescription costs data, so a reliable trend cannot be assigned. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$32K$65K2022 Medicare payment: $15,445 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $10,095 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $64,576 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022200226$15,445
202392126$10,095
20241982,041$64,576

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$660K$1.3M2022 Drug cost: $340,792 (USD; Tot_Drug_Cst)2023 Drug cost: $1,052,659 (USD; Tot_Drug_Cst)2024 Drug cost: $1,320,050 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022314791$340,792
2023278771$1,052,659
20242091,119$1,320,050

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99204New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more106106$123
96413Administration of chemotherapy into vein, 1 hour or less1418$112
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more77114$80
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more4652$48

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Humira(Cf) PenAdalimumab571,708$405,516
Enbrel SureclickEtanercept441,232$314,129
Enbrel MiniEtanercept13364$92,845
OrenciaAbatacept11308$58,443
Hydroxychloroquine SulfateHydroxychloroquine Sulfate1556,430$3,484

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.14$293Janssen Biotech, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Sreekanth Chintamaneni, M.D.?

Tedicare shows public-source Medicare data for Sreekanth Chintamaneni, M.D. (NPI 1427118280), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Sreekanth Chintamaneni, M.D. have ACO affiliation data?

Sreekanth Chintamaneni, M.D. is shown with ACO affiliation data for Kootenai Accountable Care, LLC (MSSP, ACO ID A3621), Aledade 45 CA CHC MSSP Enhanced (MSSP, ACO ID A4542), and Gundersen ACO (MSSP, ACO ID A5094).

What billing organization is linked to Sreekanth Chintamaneni, M.D.?

Sreekanth Chintamaneni, M.D. is linked to RHEUMATOLOGY ASSOCIATES PC (billing NPI 1326898594) in the available physician profile data.

Does Sreekanth Chintamaneni, M.D. have Open Payments data?

Sreekanth Chintamaneni, M.D. has 14 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.